BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28870136)

  • 41. Endotoxemia alters nucleotide hydrolysis in platelets of rats.
    Vuaden FC; Furstenau CR; Savio LE; Sarkis JJ; Bonan CD
    Platelets; 2009 Mar; 20(2):83-9. PubMed ID: 19235049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ectonucleotidase activities are altered in serum and platelets of L-NAME-treated rats.
    Fürstenau CR; Trentin Dda S; Gossenheimer AN; Ramos DB; Casali EA; Barreto-Chaves ML; Sarkis JJ
    Blood Cells Mol Dis; 2008; 41(2):223-9. PubMed ID: 18559295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8.
    Fausther M; Lecka J; Kukulski F; Lévesque SA; Pelletier J; Zimmermann H; Dranoff JA; Sévigny J
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G785-95. PubMed ID: 17095758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
    Amadio S; Apolloni S; D'Ambrosi N; Volonté C
    J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia.
    Bianco F; Fumagalli M; Pravettoni E; D'Ambrosi N; Volonte C; Matteoli M; Abbracchio MP; Verderio C
    Brain Res Brain Res Rev; 2005 Apr; 48(2):144-56. PubMed ID: 15850653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of extracellular nucleotides hydrolysis intensifies the allergic bronchospasm. A novel protective role of ectonucleotidases.
    Chávez J; Vargas MH; Rebollar-Ayala DC; Díaz-Hernández V; Cruz-Valderrama JE; Flores-Soto E; Flores-García M; Jiménez-Vargas NN; Barajas-López C; Montaño LM
    Allergy; 2013 Apr; 68(4):462-71. PubMed ID: 23414231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecules as activators in medicinal chemistry (2000-2016).
    Hameed A; Al-Rashida M; Alharthy RD; Uroos M; Mughal EU; Ali SA; Khan KM
    Expert Opin Ther Pat; 2017 Oct; 27(10):1089-1110. PubMed ID: 28673105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enzymes that hydrolyze adenine nucleotides in patients with ischemic heart disease.
    Bagatini MD; Martins CC; Gasparetto D; Spanevello RM; Becker LV; Rosa CS; Battisti V; Bellé L; Gonçalves JF; Schetinger MR; Dos Santos RB; Oliveira LZ; Morsch VM
    Clin Chim Acta; 2011 Jan; 412(1-2):159-64. PubMed ID: 20920495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Purine and pyrimidine nucleoside phosphorylases - remarkable enzymes still not fully understood].
    Bzowska A
    Postepy Biochem; 2015; 61(3):260-73. PubMed ID: 26677573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal Cancer and Purinergic Signalling: An Overview.
    Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p53-Mdm2 inhibitors: patent review (2009 - 2010).
    Kamal A; Mohammed AA; Shaik TB
    Expert Opin Ther Pat; 2012 Feb; 22(2):95-105. PubMed ID: 22316395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Xanthine oxidase inhibitors: a patent survey.
    Kumar R; Darpan ; Sharma S; Singh R
    Expert Opin Ther Pat; 2011 Jul; 21(7):1071-108. PubMed ID: 21510722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets.
    Zanini D; Schmatz R; Pimentel VC; Gutierres JM; Maldonado PA; Thomé GR; Cardoso AM; Stefanello N; Oliveira L; Chiesa J; Leal DB; Morsch VM; Schetinger MR
    Biomed Pharmacother; 2012 Feb; 66(1):40-5. PubMed ID: 22244962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MEK inhibitors: a patent review 2008 - 2010.
    Trujillo JI
    Expert Opin Ther Pat; 2011 Jul; 21(7):1045-69. PubMed ID: 21548849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells.
    Neary JT; Rathbone MP; Cattabeni F; Abbracchio MP; Burnstock G
    Trends Neurosci; 1996 Jan; 19(1):13-8. PubMed ID: 8787135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spatial mapping of ectonucleotidase gene expression in the murine urinary bladder.
    Aresta Branco MSL; Perrino BA; Mutafova-Yambolieva VN
    Front Physiol; 2023; 14():1306500. PubMed ID: 38098806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of purinergic signaling by NPP-type ectophosphodiesterases.
    Stefan C; Jansen S; Bollen M
    Purinergic Signal; 2006 Jun; 2(2):361-70. PubMed ID: 18404476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleoside and Nucleotide Analogues as Potential Therapeutics.
    Pawlowska R; Chworos A
    Curr Med Chem; 2023; 30(11):1207-1208. PubMed ID: 36872461
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies of nucleosides and nucleotides. XLI. Purine cyclonucleosides. 8. Selective sulfonylation of 8-bromoadenosine derivatives and an alternate synthesis of 8,2'-and 8,3'-S-cyclonucleosides.
    Ikehara M; Kaneko M
    Tetrahedron; 1970 Sep; 26(18):4251-9. PubMed ID: 5469477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.